The Pasteur Institute of Lille is a research centre and member of the Pasteur Institute network. It includes 14 research units and 1,150 employees including 626 researchers located in Lille, France. There are also 300 employees located outside the Pasteur site. Its revenues are above €70 million.

During the past decade, Institut Pasteur de Lille conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Pasteur de Lille" #1 sponsor was "Valbiotis" with 3 trials, followed by "Institut Pasteur de Lille" with 2 trials sponsored, "Lesaffre International" with 2 trials sponsored, "Danisco" with 1 trials sponsored and "LNC THERAPEUTICS" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Pasteur de Lille" #1 collaborator was "Biofortis Mérieux NutriSciences" with 4 trials as a collaborator, "Institut Pasteur de Lille" with 2 trials as a collaborator, "Association Française des Intolérants au Gluten (AFDIAG)" with 1 trials as a collaborator, "BioFortis" with 1 trials as a collaborator and "Institut Polytechnique UniLaSalle" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Institut Pasteur de Lille" are "Dyslipidemias" (2 trials), "Age-related Macular Degeneration" (1 trials), "Atherosclerosis" (1 trials), "Cardiovascular Risk Factor" (1 trials) and "Celiac Disease" (1 trials). Many other conditions were trialed in "Institut Pasteur de Lille" in a lesser frequency.

Most popular intervention types in "Institut Pasteur de Lille" are "Dietary Supplement" (8 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Active product" (1 trials), "Control product" (1 trials), "Infantil formula" (1 trials) and "Lynside Wall Basic" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Pasteur de Lille" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Institut Pasteur de Lille". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Institut Pasteur de Lille, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Pasteur de Lille, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".